Lactobacillus, which was proved to be remarkably decreased in COVID-19 patients[46], can produce the aryl hydrocarbon receptor (AhR) ligand-indole-3-aldehyde that promotes AhR-dependent IL22 transcription and improves resistance against mucosal inflammation[47]. Here, AHR is linked to COVID-19.